
Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome
Keywords: CTCL, cutaneous T-cell lymphoma; ECOG, Eastern Cooperative Oncology Group; IL, interleukin; MF, mycosis fungoides; rIL-2, recombinant interleukin-2; SS, Sézary syndrome; Treg, T-regulatory cells